Healthcare -
Biotechnology - NASDAQ - US
$ 1.83
-1.08 %
$ 399 M
Market Cap
-8.32
P/E
Price Target
Average
227.87%
Revenue Forecast
Estimate
35.45%
EBIT
Estimate
--91.38%
Net Income
Estimate
73.79%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Akebia Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for AKBA of $6 , with forecasts ranging from
a
low of
$6 to a high of $6 .
AKBA Lowest Price Target
Wall Street Target
6 USD
227.87%
AKBA Average Price Target
Wall Street Target
6 USD
227.87%
AKBA Highest Price Target
Wall Street Target
6 USD
227.87%
REVENUE FORECAST
Revenue Forecast Chart AKBA
EBIT FORECAST
EBIT Forecast Chart AKBA
NET INCOME FORECAST
Net Income Chart AKBA